ProVerum Medical

Dublin, Ireland Founded: 2015 • Age: 11 yrs
Developer of a minimally-invasive medical device for benign prostatic hyperplasia

About ProVerum Medical

ProVerum Medical is a company based in Dublin (Ireland) founded in 2015 by Riona Ni Ghriallais and Conor Harkin.. ProVerum Medical has raised $118.18 million across 6 funding rounds from investors including Orbimed, Enterprise Ireland and European Union. ProVerum Medical offers products and services including ProVee Stent, ProVee Delivery Device, and ProVee VPU. ProVerum Medical operates in a competitive market with competitors including Neotract, Zenflow, Urotronic, Butterfly Medical and Rivermark, among others.

  • Headquarter Dublin, Ireland
  • Founders Riona Ni Ghriallais, Conor Harkin
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Proverum Medical Ltd
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $118.18 M (USD)

    in 6 rounds

  • Latest Funding Round
    $80 M (USD), Series B

    Aug 25, 2025

  • Investors
    Orbimed

    & 12 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ProVerum Medical

ProVerum Medical offers a comprehensive portfolio of products and services, including ProVee Stent, ProVee Delivery Device, and ProVee VPU. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for treating enlarged prostate by opening urethra atraumatically

Tool for precise deployment of ProVee stent in procedures

Unit providing clear visualization for medical device procedures

Funding Insights of ProVerum Medical

ProVerum Medical has successfully raised a total of $118.18M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $80 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series B — $80.0M
  • First Round

    (01 May 2018)

  • Investors Count 13
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2025 Amount Series B - ProVerum Medical Valuation MVM
Apr, 2022 Amount Grant - ProVerum Medical Valuation

investors

Jan, 2022 Amount Series A - ProVerum Medical Valuation Gilde Healthcare
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ProVerum Medical

ProVerum Medical has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed, Enterprise Ireland and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Private equity and venture captial firm focused on healthcare sectors
Founded Year Domain Location
Venture capital fund and fund of funds focused on the life science sector
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ProVerum Medical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ProVerum Medical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Proverum Medical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ProVerum Medical

ProVerum Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neotract, Zenflow, Urotronic, Butterfly Medical and Rivermark, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Minimally invasive devices in urology
domain founded_year HQ Location
A device is developed to treat urinary obstruction from BPH.
domain founded_year HQ Location
Urethral stricture treatment devices are developed by Urotronic.
domain founded_year HQ Location
Developer of an implantable device for the treatment of benign prostatic hyperplasia (BPH)
domain founded_year HQ Location
Medical device for benign prostatic hyperplasia treatment is developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Proverum Medical

Frequently Asked Questions about ProVerum Medical

When was ProVerum Medical founded?

ProVerum Medical was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is ProVerum Medical located?

ProVerum Medical is headquartered in Dublin, Ireland.

Is ProVerum Medical a funded company?

ProVerum Medical is a funded company, having raised a total of $118.18M across 6 funding rounds to date. The company's 1st funding round was a Series A of $33.98M, raised on May 01, 2018.

What does ProVerum Medical do?

ProVerum Medical was founded in 2015 and is based in Dublin, Ireland. Operations focus on the medical device sector, where a minimally invasive implant known as ProVerum is developed to address benign prostatic hyperplasia. This condition involves prostate enlargement that leads to urination difficulties. The device is designed for targeted treatment through outpatient procedures, supporting urological care in the European market.

Who are the top competitors of ProVerum Medical?

ProVerum Medical's top competitors include Zenflow, Neotract and Rivermark.

What products or services does ProVerum Medical offer?

ProVerum Medical offers ProVee Stent, ProVee Delivery Device, and ProVee VPU.

Who are ProVerum Medical's investors?

ProVerum Medical has 13 investors. Key investors include Orbimed, Enterprise Ireland, European Union, MVM Partners, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available